Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda

British Journal of Cancer

Volumn 89, Issue 3, 2003, Pages 502-504

  Newton, R ^a   Ziegler, J ^b,e,h   Bourboulia, D ^c   Casabonne, D ^a   Beral, V ^a   Mbidde, E ^b   Carpenter, L ^d,i,j   Parkin, D M ^e   Wabinga, H ^b   Mbulaiteye, S ^b   Jaffe, H ^f   Weiss, R ^g   Boshoff, C ^c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j MRC Programme on AIDS   (Uganda)

more..

Author keywords

HIV; Kaposi's sarcoma; KSHV HHV 8; Uganda

Indexed keywords

HERPES SIMPLEX VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; HERPES SIMPLEX; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; SEROPREVALENCE; UGANDA; EPIDEMIOLOGY; FEMALE; HOSPITALIZATION; MALE; PATHOGENICITY; PATHOLOGY; RISK FACTOR; VIROLOGY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX; UGANDA;

EID: 0042978483     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601113     Document Type: Article

References (12)

1. Buchbinder A, Friedman-Kien AE (1991) Clinical aspects of epidemic Kaposi's sarcoma. In Beral V, Jaffe HW, Weiss RA (eds) Cancer, HIV and AIDS. Cancer Surveys. Volume 10. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
2. Dean AD, Dean JA, Burton JH, Dicker RC (1990) Epi Info Version 5: a word processing, database and statistics program for epidemiology on microcomputers. Centers for Disease Control, Atlanta, Georgia, USA
3. Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, Wabinga H, Mbulataiye S, Appleby P, Reeves G, Jaffe H, the Uganda Kaposi's Sarcoma Study Group (2001) A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 92: 622-627
4. Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Bourboulia D, Boshoff C, Coursaget P, the Uganda Kaposi's Sarcoma Study Group (2002) The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer 87: 301-308
5. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, the Uganda Kaposi's Sarcoma Study Group, Weiss R, Boshoff C (2003) The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus in adults with cancer, in Uganda. Int J Cancer 103: 226-232
6. Plancoulaine S, Abel L, Van Beveren M, Gessain A (2002) High titres of anti-human herpesvirus 8 antibodies in elderly males in an endemic population. J Natl Cancer Inst 94: 1333-1335
7. Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristera R, Aiuti F, Ortona L, Ensoli B (1999) Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 91: 1468-1474
8. Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Patel M, Ruff P, Bezwoda WR, Hale M, Jentsh U, Retter E, Pacella-Norman R, Bourboulia D, Whitby D, Boshoff C, Weiss R (1999) The seroepidemiology of HHV-8/KSHV in a large population of black cancer patients in South Africa. N Eng J Med 340: 1863-1871
9. STATA (2001) Stata software 2001. College Park, TX.
10. Tedeschi R, Enbom M, Bidoli E, Linde A, De-Paoli P, Dillner J (2001) Viral load of human herpesvirus-8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol 39: 4269-4273
11. Ziegler JL, Newton R, Katongole-Mbidde E, Mbulataiye S, DeCock K, Wabinga H, Mugerwa J, Katabira E, Jaffe H, Parkin DM, Reeves G, Beral V, for the Uganda Kaposi's sarcoma study group (1997) Risk factors for HIV-associated Kaposi's sarcoma in Uganda: a case - control study of 1026 adults. AIDS 11: 1619-1626
12. Ziegler J, Newton R, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Wabinga H, Mbulaiteye S, Jaffe H, the Uganda Kaposi's Sarcoma Study Group, Weiss R, Boshoff C (2003) Risk factors for Kaposi's sarcoma: a case - control study of HIV seronegative people in Uganda. Int J Cancer 103: 233-240